DiaMedica Therapeutics (DMAC) Equity Ratio (2018 - 2019)
DiaMedica Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 0.88 for Q3 2019.
- For Q3 2019, Equity Ratio changed N/A year-over-year to 0.88; the TTM value through Sep 2019 reached 0.88, changed N/A, while the annual FY2018 figure was 0.93, N/A changed from the prior year.
- Equity Ratio reached 0.88 in Q3 2019 per DMAC's latest filing, down from 0.91 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.93 in Q4 2018 to a low of 0.88 in Q3 2019.